Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Elife|February 14, 2019
Dystroglycan is a scaffold for extracellular axon guidance decisionsL Bailey Lindenmaier, Nicolas Parmentier, Caiying Guo, et al.The Journal of Biological Chemistry|August 12, 2009
The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptidesRuth Geiss-Friedlander, Nicolas Parmentier, Ulrike Möller, et al.Nature Medicine|September 23, 2003
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseCatherine Uyttenhove, Luc Pilotte, Ivan Théate, et al.Progress in Neurobiology|September 28, 2021
The Celsr3-Kif2a axis directs neuronal migration in the postnatal brainJanne Hakanen, Nicolas Parmentier, Leonie Sommacal, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 29, 2012
Analysis of the processing of seven human tumor antigens by intermediate proteasomesBenoît Guillaume, Vincent Stroobant, Marie-Pierre Bousquet-Dubouch, et al.Nature Immunology|April 6, 2010
Production of an antigenic peptide by insulin-degrading enzymeNicolas Parmentier, Vincent Stroobant, Didier Colau, et al.Journal of Medicinal Chemistry|April 14, 2026
Optimization of METTL3 Inhibitors for the Treatment of Solid Tumors and AMLGuillaume Dutheuil, Killian Oukoloff, François Lenoir, et al.Proceedings of the National Academy of Sciences of the United States of America|October 13, 2010
Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I moleculesBenoît Guillaume, Jacques Chapiro, Vincent Stroobant, et al.Journal of Medicinal Chemistry|January 30, 2025
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor ModelsGuillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.Pageof 1